Dynamic covalent chemistry-regulated stimuli-activatable drug delivery systems for improved cancer therapy
Authors:
- Qiwen ZhuQZQiwen Zhu
- Madiha SaeedMSMadiha Saeed
- Rundi SongRSRundi Song
- Tao SunTSTao Sun
- Chen JiangCJChen Jiang
- Haijun YuHYHaijun Yu
- 1 May 2020
- journal article
- review article
- Published by Elsevier in Chinese Chemical Letters
- Vol. 31 (5) , 1051-1059
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (31671024, 51873228, 31622025)
- Youth Innovation Promotion Association of Chinese Academy of Sciences (2014218)
- Fusion Grant between Fudan University
- Shanghai Institute of Materia Medica, CAS (FU-SIMM-20182006)
- Open Project Program of Key Lab of Smart Drug Delivery (Ministry of Education), Department of Pharmaceutics, School of Pharmacy, Fudan University, China
This publication has 103 references indexed in Scilit:
- Oxime Cross‐Linked Injectable Hydrogels for Catheter DeliveryAdvanced Materials, 2013
- Boronate-Mediated Biologic DeliveryJournal of the American Chemical Society, 2012
- Well‐Defined, Reversible Boronate Crosslinked Nanocarriers for Targeted Drug Delivery in Response to Acidic pH Values and cis‐DiolsAngewandte Chemie International Edition, 2012
- CD34+/CD38- stem cells in chronic myeloid leukemia express Siglec-3 (CD33) and are responsive to the CD33-targeting drug gemtuzumab/ozogamicinHaematologica, 2011
- Using the dynamic bond to access macroscopically responsive structurally dynamic polymersNature Materials, 2010
- Acetal‐Modified Dextran Microparticles with Controlled Degradation Kinetics and Surface Functionality for Gene Delivery in Phagocytic and Non‐Phagocytic CellsAdvanced Materials, 2010
- Acetal-Derivatized Dextran: An Acid-Responsive Biodegradable Material for Therapeutic ApplicationsJournal of the American Chemical Society, 2008
- Fully Degradable Hydrophilic Polyals for Protein ModificationBiomacromolecules, 2005
- Drug Delivery Systems: Entering the MainstreamScience, 2004
- Development of potent monoclonal antibody auristatin conjugates for cancer therapyNature Biotechnology, 2003